Advanced Proteome Therapeutics Corporation
APTCF · OTC
4/30/2023 | 1/31/2023 | 10/31/2022 | 7/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1,628 | $3,628 | $3,571 | $3,571 |
| - Cash | $39 | $237 | $312 | $544 |
| + Debt | $31 | $389 | $320 | $332 |
| Enterprise Value | $1,621 | $3,780 | $3,579 | $3,358 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$1,496 | -$324 | -$244 | -$109 |
| % Margin | – | – | – | – |
| Net Income | -$1,478 | -$278 | -$210 | -$76 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.036 | -0.007 | -0.005 | -0.002 |
| % Growth | -426.1% | -30.2% | -178.9% | – |
| Operating Cash Flow | -$712 | -$121 | -$252 | -$223 |
| Capital Expenditures | -$1 | -$1 | $0 | $0 |
| Free Cash Flow | -$712 | -$121 | -$252 | -$223 |